As of 2025-07-06, the Relative Valuation of Cannara Biotech Inc (LOVE.CN) is (0.70) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 CAD, the upside of Cannara Biotech Inc based on Relative Valuation is -681.1%.
The range of the Relative Valuation is (0.67) - (0.70) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.1x - 38.8x | 35.0x |
| Forward P/E multiples | 36.3x - 46.6x | 41.4x |
| Fair Price | (0.67) - (0.70) | (0.70) |
| Upside | -658.9% - -681.0% | -681.1% |
| Date | P/E |